CD8A and neoplasm: Mechanistically, studies have revealed that T-VEC treatment causes a significant shift in the tumor microenvironment, with infiltration of activated CD8+ T cells expressing both perforin and GrB; some of these T cells also displayed a memory effector phenotype, important for promoting systemic immunity [49] (summarized in Table 2).